Ex-OpenAI executive raises $215 million for AI drug development startup

The launch highlights the growing trend of leveraging AI in scientific research, emphasizing high expectations for innovation and impact. The post Ex-OpenAI executive raises $215 million for AI drug development startup appeared first on Crypto Briefing.